News ReleasesRSS
- Mar 28, 2024 Notice of Disposal of Treasury Shares as Restricted Stock Compensation Plan
- Mar 27, 2024 Chugai Obtains Approval for FoundationOne CDx Cancer Genomic Profile to Be Used as a Companion Diagnostic for the AKT Inhibitor, Capivasertib for Advanced HR-positive, HER2-negative Breast Cancer with PIK3CA, AKT1 or PTEN Alterations
- Mar 26, 2024 Mitchga Approved for Itching in Pediatric Atopic Dermatitis and Prurigo Nodularis, for its Subcutaneous Injection 30mg Vials
- Mar 26, 2024 Chugai Obtains Regulatory Approval for “Piasky 340mg” for Paroxysmal Nocturnal Hemoglobinuria in Japan
- Mar 26, 2024 Chugai Obtains Regulatory Approval for Vabysmo, the Only Bispecific Antibody in the Ophthalmology Field, for Additional Indication of Macular Edema Associated with Retinal Vein Occlusion
What's NewRSS
- Mar 28, 2024 Notice of Resolutions of the 113th Annual General Meeting
- Mar 28, 2024 Notice Regarding Year-End Dividend for the Fiscal Year ending December, 2023
- Mar 28, 2024 Finance Report (Jan-Dec2023)
- Feb 27, 2024 Notice of Convocation of the AGM of Shareholders for the Business Term ended December 31, 2023
- Feb 01, 2024 Conference on FY 2023.12 Financial Results